.avif)
San Diego, DATE, 2018 (BUSINESS WIRE) - Scientist.com, the world's leading marketplace for outsourced scientific services, and Allele Biotechnology & Pharmaceuticals Inc., a leading San Diego-based preclinical-stage biopharmaceutical company, have partnered to develop nanoantibodies for therapeutic applications. Experts selected through Scientist.com’s Genius Consulting NetworkTM will assist Allele in applying its proprietary nanoantibody technology to multiple therapeutic areas.
“Allele Biotech has developed novel cutting-edge nanoantibody technologies with considerable therapeutic potential,” stated Kevin Lustig, PhD, Scientist.com’s CEO and Founder. “This partnership enables Allele to focus on exploring therapeutic applications of its proprietary nanoantibody candidates.”
Allele’s nanoantibodies are recombinant, fully humanized, camelid single-domain heavy-chain only (VHH) antibodies that can be linked together to produce multivalent new molecular entities. With their unique structure, small size, and ability to bind multiple targets with one construct, nanoantibodies are ideal for generating novel biologics.
“Scientist.com makes it easy for us to connect with industry-leading experts in drug discovery and development,” stated Dr. Jiwu Wang, CEO of Allele Biotech. “We use the marketplace to find the experts and services we need for our internal R&D programs.”
Scientist.com’s recently launched Genius Consulting Network offers access to world-class experts in pre-clinical and clinical research, IND-enabling programs, translational research, CMC services, NDA submission and commercial assessments, among other areas.
About Allele Biotechnology & Pharmaceuticals Inc.
“Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that builds unique platforms based on cutting-edge science to generate disruptive therapies. Allele uses proprietary technology for discovery and production of single domain nanoantibodies for highly valuable and diversified targets through its own powerful workflow established over the past 9 years. To date, Allele has generated recombinant nanoantibodies against over 20 different biomedically important antigens in the fields of inflammatory diseases, cancer, and cardiovascular diseases, among others. Allele is moving a number of programs supported by in vivo data through pre-clinical stages.”
.webp)
Scientist.com
Scientist.comは、科学研究のアウトソーシングという複雑な業務のために構築された、世界最大かつ初のプラットフォームです。
私たちは、製薬・バイオテクノロジー企業が、創薬や前臨床研究から臨床開発、製造、メディカルアフェアーズ、そして商業化に至るまで、パイプラインのあらゆる段階を支えるプロバイダーとの関係を構築、管理、拡大できるよう支援しています。一元化されたプラットフォームを通じて、組織は6,000社以上のグローバルなプロバイダーネットワークにアクセスし、調達ワークフローの効率化、コンプライアンスの維持、サプライヤー関係の管理を実現するとともに、データに基づいた洞察を活用して、より迅速かつ的確な意思決定を行うことが可能です。
現在、Scientist.comは世界の製薬企業トップ30社のうち24社を含む130以上のライフサイエンス関連組織を支援しており、業務の複雑さを軽減し、開発期間を短縮し、イノベーションをより迅速に患者へ届けるためのサポートを行っています。私たちの使命は、2050年までに人類のあらゆる疾患を治癒可能にすることです。